Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Inno · SciRah

Researcher profile · Semantic Scholar

A. Inno

Share profile

A. Inno — researcher profile on SciRah

h-index: 26
Works: 129
Citations: 2,634

Most-cited papers

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
A. Cortellini, M. Tucci, V. Adamo, L. S. Stucci +36 more
2020Journal for ImmunoTherapy of Cancer239 citations Open access
Semantic Scholar
PD‐L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections
Enrico Munari, G. Zamboni, G. Lunardi, L. Marchionni +18 more
2018Journal of Thoracic Oncology153 citations Open access
Semantic Scholar
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
A. Cortellini, M. di Maio, O. Nigro, A. Leonetti +57 more
2021Journal for ImmunoTherapy of Cancer151 citations Open access
Semantic Scholar
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
S. Gori, A. Inno, L. Belluomini, P. Bocus +3 more
2019Critical reviews in oncology/hematology150 citations
Semantic Scholar
Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.
A. Inno, G. Bogina, M. Turazza, Laura Bortesi +7 more
2016The Oncologist139 citations Open access
Semantic Scholar
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
A. Cortellini, B. Ricciuti, M. Tiseo, E. Bria +46 more
2020Journal for ImmunoTherapy of Cancer92 citations Open access
Semantic Scholar
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
A. Cortellini, A. Friedlaender, G. Banna, G. Porzio +67 more
2020Clinical Lung Cancer79 citations Open access
Semantic Scholar
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients
J. Foglietta, A. Inno, F. de Iuliis, V. Sini +4 more
2017Clinical Breast Cancer76 citations
Semantic Scholar
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer.
A. Cortellini, A. D'Alessio, S. Cleary, S. Buti +54 more
2023Clinical Cancer Research70 citations Open access
Semantic Scholar
Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma.
M. Löffler, S. Gori, F. Izzo, A. Mayer-Mokler +31 more
2022Clinical Cancer Research68 citations Open access
Semantic Scholar
Rechallenge of immune checkpoint inhibitors: a systematic review and meta-analysis.
A. Inno, G. Roviello, A. Ghidini, A. Luciani +3 more
2021Critical reviews in oncology/hematology68 citations Open access
Semantic Scholar
Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity
A. Inno, G. Metro, P. Bironzo, A. Grimaldi +5 more
2017Tumori62 citations
Semantic Scholar
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
L. Cantini, G. Mentrasti, G. L. Russo, D. Signorelli +58 more
2022ESMO Open60 citations Open access
Semantic Scholar
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study
A. Cortellini, A. De Giglio, K. Cannita, D. Cortinovis +47 more
2021Thoracic Cancer48 citations Open access
Semantic Scholar
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
V. Quagliariello, I. Bisceglia, M. Berretta, M. Iovine +6 more
2023Cancers45 citations Open access
Semantic Scholar
Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
F. Petrelli, A. Iaculli, D. Signorelli, A. Ghidini +6 more
2020Journal of Clinical Medicine39 citations Open access
Semantic Scholar
Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis.
F. Petrelli, A. De Stefani, F. Trevisan, C. Parati +10 more
2019Critical reviews in oncology/hematology38 citations
Semantic Scholar
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
L. Belluomini, L. Calvetti, A. Inno, G. Pasello +5 more
2022Frontiers in Oncology37 citations Open access
Semantic Scholar
Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1
G. Gallucci, F. Turazza, A. Inno, M. Canale +5 more
2024International Journal of Molecular Sciences34 citations Open access
Semantic Scholar
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports
A. Inno, N. Maurea, G. Metro, A. Carbone +2 more
2021Cancer Immunology and Immunotherapy33 citations
Semantic Scholar
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
A. Cortellini, L. Brunetti, G. Di Fazio, E. Garbo +103 more
2025Journal for ImmunoTherapy of Cancer32 citations Open access
Semantic Scholar
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
A. Inno, A. Chiampan, L. Lanzoni, Matteo Verzé +2 more
2021Frontiers in Cardiovascular Medicine31 citations Open access
Semantic Scholar
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study
R. Berardi, C. Mastroianni, Giuseppe Lo Russo, R. Buosi +34 more
2019Therapeutic Advances in Medical Oncology27 citations Open access
Semantic Scholar
Dual-Energy CT in Oncologic Imaging
G. Foti, Giorgio Ascenti, A. Agostini, Chiara Longo +4 more
2024Tomography26 citations Open access
Semantic Scholar
In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy
V. Quagliariello, M. Berretta, I. Bisceglia, I. Giacobbe +14 more
2025Cancers25 citations Open access
Semantic Scholar
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis
A. Inno, S. Barni, A. Ghidini, A. Zaniboni +1 more
2018Breast Cancer Research and Treatment25 citations
Semantic Scholar
SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology
Alessandra Greco, M. Canale, V. Quagliariello, S. Oliva +12 more
2025International Journal of Molecular Sciences24 citations Open access
Semantic Scholar
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
M. Russano, A. Cortellini, R. Giusti, A. Russo +46 more
2021Cancer Immunology and Immunotherapy21 citations Open access
Semantic Scholar
The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST
A. Inno, Giuseppe Lo Russo, M. Salgarello, G. Corrao +8 more
2018Tumori20 citations
Semantic Scholar
Borderline resectable pancreatic cancer: More than an anatomical concept.
F. Petrelli, A. Inno, S. Barni, A. Ghidini +4 more
2017Digestive and Liver Disease20 citations
Semantic Scholar
Current treatment options for HER2-positive breast cancer patients with brain metastases.
D. Galanti, A. Inno, M. La Vecchia, N. Borsellino +3 more
2021Critical reviews in oncology/hematology19 citations
Semantic Scholar
Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review.
F. Petrelli, A. Inno, A. Ghidini, L. Rimassa +3 more
2017European Journal of Cancer18 citations
Semantic Scholar
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
S. Gori, F. Puglisi, S. Moroso, A. Fabi +19 more
2019Clinical Breast Cancer16 citations Open access
Semantic Scholar
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients
V. Quagliariello, M. Berretta, I. Bisceglia, I. Giacobbe +12 more
2024Cancers15 citations Open access
Semantic Scholar
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis
A. Inno, L. Tarantini, I. Parrini, P. Spallarossa +5 more
2023Current Oncology Reports15 citations
Semantic Scholar
Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database
Lan Yang, Yuwen Zhou, G. Wang, Dan Liu +9 more
2021Translational Lung Cancer Research15 citations Open access
Semantic Scholar
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
D. Santini, T. Zeppola, M. Russano, F. Citarella +44 more
2021Journal of Translational Medicine15 citations Open access
Semantic Scholar
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
F. Facchinetti, Sara Pilotto, G. Metro, E. Baldini +12 more
2019Tumori14 citations
Semantic Scholar
Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 years
F. Petrelli, A. Inno, A. Ghidini, S. Gori +1 more
2020Cancer Immunology and Immunotherapy13 citations Open access
Semantic Scholar
Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer?
A. Inno, A. Stagno, S. Gori
2018Translational Lung Cancer Research12 citations Open access
Semantic Scholar
Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data
V. Damuzzo, L. Gasperoni, L. Del Bono, A. Ossato +2 more
2025Frontiers in Oncology11 citations Open access
Semantic Scholar
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition
V. Quagliariello, M. Berretta, I. Bisceglia, M. Iovine +14 more
2025International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Pretreatment lung immune prognostic index as biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab.
A. Veccia, V. Sforza, E. Vattemi, A. Inno +6 more
2021Immunotherapy10 citations
Semantic Scholar
Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)
M. Dieci, F. Massari, R. Giusti, A. Inno +8 more
2018ESMO Open10 citations Open access
Semantic Scholar
Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity
V. Quagliariello, Annabella Di Mauro, G. Ferrara, F. Bruzzese +15 more
2025Antioxidants9 citations Open access
Semantic Scholar
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
A. Cortellini, S. Buti, M. Bersanelli, R. Giusti +45 more
2020Oncoimmunology9 citations Open access
Semantic Scholar
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world
F. Terracciani, A. De Vincentis, Daphne D'Amato, L. Cristoferi +150 more
2025JHEP Reports8 citations Open access
Semantic Scholar
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors.
L. Incorvaia, G. Madonia, L. Corsini, A. Cucinella +12 more
2021Critical reviews in oncology/hematology8 citations
Semantic Scholar
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management
G. Gallucci, Mario Larocca, A. Navazio, F. Turazza +11 more
2025International Journal of Molecular Sciences7 citations Open access
Semantic Scholar
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study
A. Inno, A. Veccia, E. D'Argento, F. Morgillo +29 more
2025Cancer Immunology and Immunotherapy7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Gori×20
Invite
S. Gori — researcher profile on SciRah
M. Russano×11
Invite
M. Russano — researcher profile on SciRah
R. Giusti×11
Invite
R. Giusti — researcher profile on SciRah
A. Cortellini×10
Invite
A. Cortellini — researcher profile on SciRah

×10

Invite

F. Rastelli — researcher profile on SciRah

Invite

M. Filetti — researcher profile on SciRah

A. Gelibter×10

Invite

A. Gelibter — researcher profile on SciRah

Invite

R. Chiari — researcher profile on SciRah

Invite

F. Zoratto — researcher profile on SciRah

Invite

M. De Tursi — researcher profile on SciRah

C. Ficorella×9

Invite

C. Ficorella — researcher profile on SciRah

P. Di Marino×9

Invite

P. Di Marino — researcher profile on SciRah